Bradley Merrill Thompson, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was quoted in BrightInsight, in “Regulatory Uncertainty Persists Around Medical Software,” by Mike Righter.

Following is an excerpt:

On January 7th the FDA announced the launch of a new streamlined regulatory framework for digital health devices. Specifically, the framework is initially focused on products which the FDA classifies as “software as a medical device” or SaMD, and the framework may eventually be expanded to all medical device software.

For those of you who are not familiar with SaMD, this includes software intended to be used for a medical purpose and that is not part of a hardware medical device. Examples of SaMD include smart drug dosing algorithms, (some) clinical decision support software, personalized patient interventions, and more.

The new framework is adapted from the typical de novo 510(k) review process where there is no option for establishing substantial equivalence since there are no available predicate devices – or in this case, predicate software. …

This announcement marks yet another update from the FDA on how it plans to regulate digital health solutions.

The numerous updates on digital health from the FDA in recent years suggest that regulations for software products will evolve at an increasing pace, adding complexity to biopharma and medtech companies’ already demanding regulatory responsibilities.

I caught up with Bradley Merrill Thompson, Medical Device, Digital Health and Combination Product Regulatory Attorney from Epstein Becker Green on the most recent FDA announcement.

“Over the last several years FDA has been churning out new guidance and regulations applying broadly to medical devices and specifically to software as a medical device.  While policymakers generally say they want to encourage innovation, these new requirements often add significant complexity and unfortunately confusion to an already dense regulatory system. For those who may be new to the health technology space, or who simply lack the internal dedicated resources to monitor the regulatory landscape carefully, it seems to me the best way to succeed is to partner with a medical device manufacturer that has the experience with FDA regulation necessary to succeed.”

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.